A comparison of two combined iron-folic acid preparations in the prevention of anaemia in pregnancy.
D000747:Anemia, Hypochromic / Q000517:prevention & control*; D004311:Double-Blind Method; D005260:Female; D005296:Ferrous Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006452:Hemoglobinometry; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*
D005296:Ferrous Compounds; D006397:Hematinics; C020748:ferrous sulfate; D007501:Iron; C030676:ferroglycine sulfate; D005998:Glycine